Tsumura & Co. (TYO:4540)

Market Cap	301.16B -12.1%
Revenue (ttm)	189.50B +10.3%
Net Income	29.01B +7.0%
EPS	386.55 +8.2%
Shares Out	74.54M
PE Ratio	10.45
Forward PE	11.49
Dividend	152.00 (3.68%)
Ex-Dividend Date	Mar 30, 2026

Volume	438,600
Average Volume	328,210
Open	4,062.00
Previous Close	4,040.00
Day's Range	3,988.00 - 4,085.00
52-Week Range	3,306.00 - 4,568.00
Beta	-0.06
RSI	45.97
Earnings Date	Feb 6, 2026

About Tsumura & Co.

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal and throat inflammation symptoms. It also offers over-the-counter Kampo medicines. The company was founded in 1893 and is headquartered in Tokyo, Japan.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,272
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In fiscal year 2025, Tsumura & Co.'s revenue was 181.09 billion, an increase of 20.05% compared to the previous year's 150.85 billion. Earnings were 32.43 billion, an increase of 94.10%.